Inventor · disambiguated record
Patricia C. Contreras
Also filed as: CONTRERAS PATRICIA · CONTRERAS PATRICIA C
11 granted patents·1 pending application·130 citations·filing 1984–2001
89Inventor score
Top patents by PatentIndex Score
12 records- 0183US5516771AUse of indolocarbazole derivatives to treat a pathological condition of the prostateCEPHALON INC·Filed 1994·Granted May 14, 1996·45 cites·12 claims
- 0271US5654427AIndolocarbazole derivatives to treat a pathological condition of the prostateKYOWA HAKKO KOGYO KK·Filed 1995·Granted Aug 5, 1997·26 cites·18 claims
- 0364US5055468AUse of bridged tricyclic amine derivatives as anti-ischemic agentsSEARLE & CO·Filed 1989·Granted Oct 8, 1991·30 cites·15 claims
- 0458US5130330ANitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for cns disordersSEARLE & CO·Filed 1990·Granted Jul 14, 1992·11 cites·3 claims
- 0554US5739158ANitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS disordersUS ARMY·Filed 1991·Granted Apr 14, 1998·4 cites·15 claims
- 0647US5401755AN-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injurySEARLE & CO·Filed 1991·Granted Mar 28, 1995·3 cites·13 claims
- 0740US4598153AMetaphit, a specific acylating agent for the [3 H] phencyclidineUS HEALTH·Filed 1984·Granted Jul 1, 1986·7 cites·1 claims
- 0838US5604255AN-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injuryUS ARMY·Filed 1994·Granted Feb 18, 1997·1 cites·8 claims
- 0937US2001034373A1Low dose modafinil for enhancement of cognitive functionFiled 2001·Application pending·0 cites
- 1030USH1899HDiagnostic uses of IGFBP-2CEPHALON INC·Filed 1996·Granted Oct 3, 2000·1 cites·2 claims
- 1130US4762846AMetaphit and related compounds as acylating agents for the (3H)phencyclidine receptorsUS HEALTH·Filed 1986·Granted Aug 9, 1988·0 cites·1 claims
- 1225US5192762AUse of bridged tricyclic amine derivatives as anti-ischemic agentsGRAY NANCY M·Filed 1991·Granted Mar 9, 1993·2 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →